跳至主要内容
临床试验/NCT02060981
NCT02060981Unknown不适用

Primary Medication Adherence Phase 2 Evaluation of a Decision Support Tool

Brigham and Women's Hospital2 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2014年2月最近更新:
适应症

试验速览

阶段
不适用
入组人数
140
试验地点
2
主要终点
Cumulative incidence of antihypertensive medication fills

研究概览

简要总结

Investigators will conduct a randomized trial with patients, through one-on-one interviews, to evaluate their understanding of and willingness to use a decision support tool and to determine if receiving and discussing the decision support tool improves the likelihood that a patient is adherent to a new antihypertensive medication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
25 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • does not pick up a prescription for a new antihypertensive medication within 14 days as identified by CVS pharmacy, their retail pharmacy provider.
  • High blood pressure diagnosis

排除标准

  • under age 25.

结局指标

主要结局

Cumulative incidence of antihypertensive medication fills

时间窗: 6 months

The proportion of patients in each group who picked up a prescription for an antihypertensive medication in any class during the follow-up period. Investigators will calculate cumulative incidences among all patients, whether or not they successfully completed the interview or returned the paper-based survey (Intention to Treat) and among only those patients who did complete the interview or returned the paper-based survey (As Treated).

次要结局

  • Patient Interviews(5 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jennifer Polinski

Assistant Professor and Epidemiologist

Brigham and Women's Hospital

研究点 (2)

Loading locations...

相似试验